Table 1.
Characteristics of optimal immune responders with sustained viral load after seven years of antiretroviral therapy (ART) and healthy HIV negative adults.
| Patient characteristics | ART-treated optimal respondersa | Healthy HIV-negative controls |
|---|---|---|
| Age in years (median) | 40 (38, 46) | 36 (33, 42) |
| Female gender n (%) | 26 (87) | 19 (63) |
| Baseline CD4 count cells/μl; median (IQR) | 97 (11, 158) | N/A |
| Current CD4 cells/μl median (IQR) | 607 (759, 996) | N/A |
| BMI; median (IQR) | 23 (20,25) | 26 (22, 30) |
| Family history of | 6.7 | 7.9 |
| hypertension (%) | ||
| Family history of diabetes | 3.3 | 3.2 |
| Febrile illness | 0 | 0 |
| Current regimen | ||
| ZDV-3TC-NVP (%) | 56.7 | N/A |
| ZDV-3TC-EFV (%) | 30.0 | N/A |
| TDF-3TC-EFV (%) | 3.3 | N/A |
a
All HAART-treated adults had sustained viral suppression for seven years. IQR, interquartile range, BMI, body mass index, ZDV, zidovudine, 3TC, lamivudine, EFV, efavirenz, TDF, tenofovir.